New treatment option for Cancer
Official title High-Resolution PET-CT Imaging for Surgical Margin Visualization
ClinicalTrials.gov ID: NCT06915454
What this study is testing
- What it's testing
- Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are anticipated given the diagnostic and non-invasive, 'ex vivo' nature of device use.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Biopsy confirmed diagnosis of any solid malignancy
- Diagnosis of any T stage, any subsite that are scheduled to undergo definitive en bloc surgical resection. Patients with recurrent disease or a new...
- Planned standard of care oncologic surgery with curative intent
- Male or female patients age ≥ 18 years
- Have life expectancy of more than 12 weeks
You likely can't join if
- General or local contraindications for resective surgery
- Women who are pregnant or breast-feeding
- Blood glucose level over 200 mg/dL prior to 18F-FDG infusion
- Any participation in other clinical trials or research study that involved a radiation exposure of more than 1 mSv in the past year. If the...
See the full eligibility criteria
- Biopsy confirmed diagnosis of any solid malignancy
- Diagnosis of any T stage, any subsite that are scheduled to undergo definitive en bloc surgical resection. Patients with recurrent disease or a new primary will be allowed.
- Planned standard of care oncologic surgery with curative intent
- Male or female patients age ≥ 18 years
- Have life expectancy of more than 12 weeks
- Karnofsky performance status of at least 70% or ECOG/Zubrod level 1
- Have acceptable glucose status (\<200 mg/dL) at Day of Surgery prior to 18F-FDG injection
- General or local contraindications for resective surgery
- Women who are pregnant or breast-feeding
- Blood glucose level over 200 mg/dL prior to 18F-FDG infusion
- Any participation in other clinical trials or research study that involved a radiation exposure of more than 1 mSv in the past year. If the participant had radiation exposure greater than 1 mSv as SOC, they would not be...
The study team makes the final eligibility decision.
Where it's taking place
- Nashville, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nashville, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.